NANOG and colorectal carcinoma: As presented in Fig. 8A–E, circFNDC3B or RNF41 decreased the expression of OCT4, Nanog, SOX2, and CD133, while ASB6 overexpression resulted in a rebound of these stemness markers in CRC cells.